A study revealed minimal overall gut microbiome differences in young adults with Major Depressive Disorder (MDD) compared to healthy peers. However, specific bacteria types were linked to the severity of depression and anxiety.
Scientists have discovered that rapid-acting antidepressants like ketamine, psilocybin, and scopolamine can alter negative mood biases in rodent models, a symptom common in depressive disorders. This breakthrough, published in Science Translational Medicine, suggests new approaches to treat Major Depressive Disorder...
In a study involving over 2,000 participants, researchers found that minor increases in individual depressive symptoms predicted subsequent weight gain, especially in individuals with higher BMI, highlighting the nuanced link between mental health and weight gain.
A recent study published in psychology journal Acta Psychologica has uncovered a significant relationship between persistent negative self-referent thinking and current depressive symptoms in adolescents. The research reveals that while such thinking patterns are associated with depression levels at the...
A new study suggests that ketamine significantly improves depression and anhedonia symptoms by altering brain connectivity in the anterior cingulate cortex, specifically influencing different subregions linked to mood regulation and reward processing. The findings have been published in Translational Psychiatry.
Home-based brain stimulation, coupled with digital psychological interventions, was ineffective in treating major depression. This conclusion came after a clinical trial conducted in São Paulo, Brazil, challenging earlier assumptions about the potential benefits of this accessible treatment method.
A recent study found that individuals with depression show heightened brain activity in specific areas when perceiving gestures, with different responses to instrumental and expressive gestures.
A study in China found that combining omega-3 supplements with Paxil more effectively treated depression in adolescents, improving symptoms and cognitive function better than Paxil alone. The study was published in the Journal of Affective Disorders.
Repetitive transcranial magnetic stimulation shows promise as an effective, well-tolerated treatment for major depressive disorder with a seasonal pattern. This non-invasive technique could expand treatment options for seasonal depression.
A recent study reveals that individuals with major depressive disorder are more prone to disordered eating, providing a new understanding of mental health's impact on eating behaviors. The findings have been published in the Journal of Psychiatric Research.
Artificial intelligence (AI) shows great promise in revolutionizing the diagnosis and treatment of depression, offering more accurate diagnoses and predicting treatment responses. While AI tools like ChatGPT align more closely with clinical guidelines, research also points towards the potential of...
A recent study found that "Super Mario Odyssey" reduced depression symptoms more than cognitive training or standard treatments, with participants showing higher motivation and selective memory improvements.
A neuroimaging study in South Korea found that women with major depressive disorder have lower taurine levels in the brain's hippocampus. This discovery offers a new potential biomarker for diagnosing depression.
Psilocybin-assisted group therapy might help reduce depression in cancer patients. This innovative approach, blending psychedelic effects with psychological support, has demonstrated promising results in improving mental health and quality of life for these patients.
A new study shows how depression alters brain connectivity, particularly in the habenula, and how ketamine treatment reverses these changes. This research enhances understanding of depression and ketamine's rapid antidepressant effects.